Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia.

Published in: BMC hematology (2018)

Indirect comparison of alternative azacitidine dosing regimens in MDS and AML shows a benefit for the 7-day regimen in attaining ORR. Additional RCTs are required to definitively address this comparison.

Keyphrases

acute myeloid leukemia
systematic review
allogeneic hematopoietic stem cell transplantation
meta analyses
clinical evaluation